John Hancock Premium Dividend Fund – NYSE:PDT

Add to watchlist

$13.34

+0.83

+6.72%

Market closed

Open in 2 days

+5.93%

month

+5.93%

quarter

+17.59%

year

Market Cap	607.43M
Enterprise value	988.51M

P/E	12.03
EV/Sales	17.78
EV/EBITDA	N/A
Price/Sales	11.05
Price/Book	1.02
PEG ratio	-0.09
EPS	-0.89

Revenue	53.38M
EBITDA	-88.91M
Income	-44.67M
Revenue Q/Q	N/A
Revenue Y/Y	N/A

Profit margin	91.88%
Oper. margin	83.62%
Gross margin	100%
EBIT margin	83.62%
EBITDA margin	-166.58%

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

John Hancock Premium Dividend Fund (NYSE:PDT): Profit margin
Jan 2023	13.64M	3.45M	25.33%
Apr 2023	13.64M	3.45M	25.33%
Jul 2023	13.04M	-25.79M	-197.73%
Oct 2023	13.04M	-25.79M	-197.73%

John Hancock Premium Dividend Fund (NYSE:PDT): Payout ratio
Payout ratio	97.97%

John Hancock Premium Dividend Fund (NYSE:PDT): Dividend Yield
2019	6.65%
2020	9.38%
2021	6.78%
2022	8.11%
2023	11.42%

John Hancock Premium Dividend Fund (NYSE:PDT): Debt to assets
Jan 2023	973573447	375.49M	38.57%
Apr 2023	973573447	1.71M	0.18%
Jul 2023	898197421	377.34M	42.01%
Oct 2023	898197421	3.56M	0.4%

John Hancock Premium Dividend Fund (NYSE:PDT): Cash Flow
Jan 2023	13.73M	-13.73M
Apr 2023	13.73M	-13.73M
Jul 2023	12.77M	-12.84M
Oct 2023	12.77M	-12.84M

John Hancock Premium Dividend Fund
Insider Trading

John Hancock Premium Dividend Fund (NYSE:PDT): Insider trades (number of shares)
Period	Buy	Sel
Jan 2024	1336	0
Dec 2024	890	0

Transaction	Date	Insider	Security	Shares	Price per share	Total value
Purchase	23 Dec 2024	ELLISON NONI L other: Trustee of the Fund other: Trustee of the Fund	common shares of beneficial ownership	890	$12.64	$11,250
Purchase	2 Jan 2024	GARFIELD DEAN director director	Common Shares of Beneficial Interest	1,336	$12.03	$16,072
Purchase	12 Oct 2023	ELLISON NONI L director director	Common Shares of Beneficial Interest	1,185	$9.35	$11,077
Sale	5 Aug 2022	PRUCHANSKY STEVEN R director: director:	common shares of beneficial interest	2,611	$15.66	$40,888
Purchase	17 Nov 2020	RATHKE FRANCES G other: Trustee of the Fund other: Trustee of the Fund	common shares of beneficial interest	715	$13.98	$9,992
Sale	30 Sep 2016	MCCLELLAN HASSELL H other: Trustee of the Fund other: Trustee of the Fund	common shares of beneficial interest	244	N/A	N/A
Purchase	4 Jan 2016	BOYLE JAMES other: Trustee of the Fund other: Trustee of the Fund	common shares of beneficial interest	1,103	N/A	N/A
Purchase	10 Feb 2014	OATES JAMES M other: Trustee of the Fund other: Trustee of the Fund	common shares of beneficial interest	162	N/A	N/A
Purchase	21 Nov 2013	MCCLELLAN HASSELL H other: Trustee of the Fund other: Trustee of the Fund	common shares of beneficial interest	30	N/A	N/A
Purchase	18 Nov 2013	CUNNINGHAM WILLIAM H DR other: Trustee of the Fund other: Trustee of the Fund	common shares of beneficial interest	50	N/A	N/A

PDT insider trading transactions

John Hancock Premium Dividend Fund
Latest News

Thursday, 12 December 2024
16:12	JOHN HANCOCK CLOSED-END FUNDS ANNOUNCE RENEWAL OF SHARE REPURCHASE PLANS	prnewswire.com
Monday, 2 December 2024
16:27	JOHN HANCOCK CLOSED-END FUNDS DECLARE MONTHLY DISTRIBUTIONS	prnewswire.com
Friday, 29 November 2024
13:14	JOHN HANCOCK PREMIUM DIVIDEND FUND NOTICE TO SHAREHOLDERS - SOURCES OF DISTRIBUTION UNDER SECTION 19(a)	prnewswire.com
Monday, 18 November 2024
00:43	My 9.5% Income Portfolio CEFs And Classic Cars	seekingalpha.com
Tuesday, 5 November 2024
06:50	Endeavour Silver Announces Q3 2024 Financial Results; Earnings Call at 10AM PDT (1PM EDT) Today	globenewswire.com
Friday, 1 November 2024
16:31	JOHN HANCOCK CLOSED-END FUNDS DECLARE MONTHLY DISTRIBUTIONS	prnewswire.com
Thursday, 31 October 2024
16:05	JOHN HANCOCK PREMIUM DIVIDEND FUND NOTICE TO SHAREHOLDERS - SOURCES OF DISTRIBUTION UNDER SECTION 19(a)	prnewswire.com
10:32	Biofrontera Inc. Announces Highly Significant Results In Phase 3 Study Of Ameluz®-Photodynamic Therapy (PDT) Regarding The Treatment Of Superficial Basal Cell Carcinoma (sBCC)	globenewswire.com
Monday, 28 October 2024
15:58	PDT: Positive Outlook Driven By Interest Rates	seekingalpha.com
Thursday, 17 October 2024
11:15	My 9.5% Income Portfolio-Fifty Shades Of Blue	seekingalpha.com
Monday, 14 October 2024
10:30	Biofrontera Inc. Announces Database Lock Of Phase 3 Study Of Ameluz®-Photodynamic Therapy (PDT) In The Treatment Of Superficial Basal Cell Carcinoma (sBCC)	globenewswire.com
Tuesday, 1 October 2024
16:29	JOHN HANCOCK CLOSED-END FUNDS DECLARE MONTHLY DISTRIBUTIONS	prnewswire.com
Monday, 30 September 2024
16:24	JOHN HANCOCK PREMIUM DIVIDEND FUND - NOTICE TO SHAREHOLDERS - SOURCES OF DISTRIBUTION UNDER SECTION 19(a)	prnewswire.com
Friday, 30 August 2024
16:11	JOHN HANCOCK PREMIUM DIVIDEND FUND - NOTICE TO SHAREHOLDERS - SOURCES OF DISTRIBUTION UNDER SECTION 19(a)	prnewswire.com
Thursday, 15 August 2024
15:22	PDT: Benefiting From Current Market Trends And Looking Good For Income	seekingalpha.com
Thursday, 1 August 2024
06:50	Endeavour Silver Announces Q2 2024 Financial Results; Earnings Call at 10AM PDT (1PM EDT) Today	globenewswire.com
Wednesday, 31 July 2024
16:53	JOHN HANCOCK PREMIUM DIVIDEND FUND NOTICE TO SHAREHOLDERS - SOURCES OF DISTRIBUTION UNDER SECTION 19(a)	prnewswire.com
Monday, 1 July 2024
16:20	JOHN HANCOCK CLOSED-END FUNDS DECLARE MONTHLY DISTRIBUTIONS	prnewswire.com
Friday, 28 June 2024
16:25	JOHN HANCOCK PREMIUM DIVIDEND FUND - NOTICE TO SHAREHOLDERS - SOURCES OF DISTRIBUTION UNDER SECTION 19(a)	prnewswire.com
Monday, 3 June 2024
16:24	JOHN HANCOCK CLOSED-END FUNDS DECLARE MONTHLY DISTRIBUTIONS	prnewswire.com
Friday, 31 May 2024
16:23	JOHN HANCOCK PREMIUM DIVIDEND FUND - NOTICE TO SHAREHOLDERS - SOURCES OF DISTRIBUTION UNDER SECTION 19(a)	prnewswire.com
Thursday, 30 May 2024
09:06	PDT: Utility And Financial Exposure At A Discount	seekingalpha.com
Monday, 20 May 2024
06:00	Arrowhead Pharmaceuticals Presents New Clinical Data Showing ARO-RAGE Achieves High Level of Gene Knockdown in Patients with Asthma	https://www.businesswire.com
Tuesday, 30 April 2024
16:20	JOHN HANCOCK PREMIUM DIVIDEND FUND NOTICE TO SHAREHOLDERS - SOURCES OF DISTRIBUTION UNDER SECTION 19(a)	prnewswire.com
Sunday, 14 April 2024
09:11	4 Closed-End Fund Buys In The Month Of March 2024	Seeking Alpha
Monday, 19 February 2024
07:57	PDT: Don't Be Fooled By The Price Performance, This 9.10%-Yielding Fund Is Not Bad	Seeking Alpha
Saturday, 17 February 2024
09:52	These 7% Dividends Prove This Investment ‘Rule' Is Total Rubbish	Forbes
Friday, 26 January 2024
09:00	The 8% Income Portfolio: 2023 Year-End Review	Seeking Alpha
Saturday, 20 January 2024
17:00	CEF Weekly Review: Take Care With CEF Sector Designation	Seeking Alpha
Saturday, 6 January 2024
10:13	My Top 10 Closed-End Fund Holdings: December 2023	Seeking Alpha

Frequently Asked Questions (FAQ)

What's the price of John Hancock Premium Dividend Fund stock today?

One share of John Hancock Premium Dividend Fund stock can currently be purchased for approximately $13.34.
When is John Hancock Premium Dividend Fund's next earnings date?

Unfortunately, John Hancock Premium Dividend Fund's (PDT) next earnings date is currently unknown.
Does John Hancock Premium Dividend Fund pay dividends?

Yes, John Hancock Premium Dividend Fund pays dividends and its trailing 12-month yield is 7.92% with 98% payout ratio. The last John Hancock Premium Dividend Fund stock dividend of $0.1 was paid on 31 Jan 2022.
How much money does John Hancock Premium Dividend Fund make?

John Hancock Premium Dividend Fund has a market capitalization of 607.43M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 18.79% to -42.95M US dollars.
What is John Hancock Premium Dividend Fund's stock symbol?

John Hancock Premium Dividend Fund is traded on the NYSE under the ticker symbol "PDT".
What is John Hancock Premium Dividend Fund's primary industry?

Company operates in the Financial Services sector and Asset Management industry.
How do i buy shares of John Hancock Premium Dividend Fund?

Shares of John Hancock Premium Dividend Fund can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
When John Hancock Premium Dividend Fund went public?

John Hancock Premium Dividend Fund is publicly traded company for more then 35 years since IPO on 15 Dec 1989.
What is John Hancock Premium Dividend Fund's official website?

The official website for John Hancock Premium Dividend Fund is jhinvestments.com.
Where are John Hancock Premium Dividend Fund's headquarters?

John Hancock Premium Dividend Fund is headquartered at 601 Congress Street, Boston, MA.
How can i contact John Hancock Premium Dividend Fund?

John Hancock Premium Dividend Fund's mailing address is 601 Congress Street, Boston, MA and company can be reached via phone at +61 76632430.

John Hancock Premium Dividend Fund

jhinvestments.com

Exchange:

NYSE

Full time employees:

Industry:

Asset Management

Sector:

Financial Services

John Hancock Premium Dividend Fund is a closed ended equity mutual fund launched and managed by John Hancock Investment Management LLC. It is co-managed by John Hancock Asset Management. The fund invests in the public equity markets of the United States. It seeks to invest in stocks of companies operating across diversified sectors, with an emphasis on the utilities sector. The fund primarily invests in dividend paying preferred stocks and common stocks of companies. It benchmarks the performance of its portfolio against a composite benchmark comprised of 70% Bank of America Merrill Lynch Preferred Stock DRD Eligible Index and 30% S&P 500 Utilities Index. The fund was formerly known as John Hancock Patriot Premium Dividend Fund II. John Hancock Premium Dividend Fund was formed on December 21, 1989 and is domiciled in the United States.

+61 76632430

601 Congress Street
Boston, MA 02210-2805

CIK: 0000855886
ISIN: US41013T1051
CUSIP: 41013T105